(NewsNation) — Doctors are currently testing a vaccine for breast cancer they say can stop cancerous tumors from forming before they start.
Breast cancer is the second-leading cause of cancer death in women younger than 50, according to the American Cancer Society. The number of younger women being diagnosed with the disease has increased 1.5% each year since 2012.
The vaccine, being developed by biotech company Anixa Biosciences, is nearing the end of its phase one trials and moving on to round two. Dr. Amit Kumar, the CEO of Anixa, joined NewsNation's "Elizabeth Vargas Reports" and said women in the trial responded well to the vaccine, and there are no safety concerns with it.
"Our approach is not to try and deal with the underlying cause, our approach is to train the immune system to